Neuroscience, Clinical Evidence, and the Future of Psychiatric Classification in DSM-5

Back to table of contents Previous article Next article PerspectivesFull AccessNeuroscience, Clinical Evidence, and the Future of Psychiatric Classification in DSM-5David J. Kupfer, M.D., and Darrel A. Regier, M.D., M.P.H.David J. Kupfer, M.D., and Darrel A. Regier, M.D., M.P.H.Published Online:1 Jul 2011https://doi.org/10.1176/appi.ajp.2011.11020219AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail In the initial stages of development of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), we expected that some of the limitations of the current psychiatric diagnostic criteria and taxonomy would be mitigated by the integration of validators derived from scientific advances in the last few decades. Throughout the last 25 years of psychiatric research, findings from genetics, neuroimaging, cognitive science, and pathophysiology have yielded important insights into diagnosis and treatment approaches for some debilitating mental disorders, including depression, schizophrenia, and bipolar disorder.In A Research Agenda for DSM-V (1), we anticipated that these emerging diagnostic and treatment advances would impact the diagnosis and classification of mental disorders faster than what has actually occurred. This optimism was not wasted, however. First, it stimulated a series of international research planning conferences supported by the National Institutes of Health that formed the basis of early deliberations by the DSM-5 task force and work groups. For example, one conference provided a detailed examination of the heterogeneity and overlap of disorders characterized by fear and avoidance, including posttraumatic stress disorder, panic/agoraphobia, social phobia/social anxiety disorder, and specific phobias (2). Though these are phenotypically heterogeneous, neuroimaging and neuroanatomy data from human and animal model studies suggest a shared membership in a “stress-induced and fear circuitry spectrum,” which is conceptually and clinically distinct from other anxiety disorders, such as generalized anxiety disorder, obsessive-compulsive disorder, and impulse control disorders. This new conceptualization has important implications for assessment, treatment, and research.The review of neuroscientific evidence for establishing groups of disorders with shared criteria, and possibly shared etiologies, also bolstered broader discussions on the overall organization of diagnostic categories across DSM-5. The role of neuroscience research findings in shaping these “metastructure” talks was most prominent in the proposal for 11 external validators (3) to help define and group diagnoses. Among these validators are shared genetic risk, familiality, shared neural substrates, and shared biomarkers. Furthermore, our recognition of the significance of neuroscience and genetics in psychiatric diagnosis has supported DSM-5's novel integration of neurobiologic findings, such as inclusion within the text that accompanies diagnostic criteria sets the potential role of these factors in shaping risk and prognosis. While not central to the criteria themselves, this information is nonetheless useful and informative for helping DSM provide a more precise picture of the clinical realities of psychiatric diagnosis.The seminal article by Robins and Guze (4) on diagnostic validity, which proposed a classification of psychiatric illnesses based not on psychodynamic, a priori hypotheses but rather on external, empirical indicators, built a direct pathway to DSM-III. Their proposed classification steps included identifying core clinical features, conducting differential diagnosis to separate the condition from similar disorders, gathering laboratory data, assessing temporal stability of the diagnosis, and determining familial aggregation of the disorder. The resultant explicit criteria featured in DSM-III and subsequent editions have significantly improved our understanding of psychiatric disorders, but they did not come without a price (5). While diagnostic reliability has thrived, large-scale epidemiological studies have underscored the inefficiency of DSM's criteria in accurately differentiating diagnostic syndromes, especially in community samples. With reification of the criteria through revised editions of DSM-III-R and DSM-IV, proliferation of diagnostic comorbidities and overreliance on the “not otherwise specified” category have continued.We realized from our Research Agenda (1) conference series that we would not be able to accomplish by DSM-5's deadline all of the things we set out to and, in fact, that portions of that agenda related to advances in neuroscience were already being addressed in other arenas. A logical extension of those discussions, as detailed in our Research Agenda (1) articles, is the Research Domain Criteria (RDoC) initiative recently launched by the National Institute of Mental Health (NIMH). A commentary by Insel and colleagues (6) introduced readers to the working principles behind the RDoC, whose proposed reclassification of mental disorders for research purposes is predicated on a neuroscience-based framework that can contribute to a nosology in which disorders are grouped by underlying pathophysiological similarities rather than phenomenological observations. This NIMH objective is consistent with our research planning conferences and conclusions, which underscored our commitment to examining evidence from neurobiology and assessing the readiness of proposed revisions for DSM-5. We are pleased with the work on RDoC that is being undertaken, and we believe this initiative will be very informative for subsequent versions: DSM-5.1, DSM-5.2, and beyond.Beyond keeping pace with the science of psychiatry, many of DSM-5's proposed changes represent an opportunity to improve the field from clinical and public health perspectives. The proposal for a single “autism spectrum disorder” category that would include the current DSM-IV diagnoses of autistic disorder (autism), Asperger's disorder, childhood disintegrative disorder, and pervasive developmental disorder not otherwise specified was born from data suggesting that these disorders share a pathophysiological substrate. Changes in the wording of the criteria, however, help clarify symptom manifestation and provide diagnosticians with a more accurate example of how these children actually appear in clinics. Similarly, a proposal from the Psychotic Disorders Work Group for an “attenuated psychosis syndrome” diagnosis was developed largely because of the sizable body of literature on psychosis risk and vulnerability factors detailing structural and functional imaging, neurocognition, and genetic outcomes. Clinically, this proposal may aid clinicians in early detection and intervention for help-seeking individuals at risk for a future psychotic disorder. Our current thinking about criteria specifically and the classification of diagnoses in DSM-5 as a whole is consistent with observations from research on heritability, treatment similarity, and shared genetic risk factors among disorders, including neurodevelopmental disorders, mood disorders, anxiety disorders, and schizophrenia spectrum disorders (7), while also supporting our philosophy that DSM-5 remains first and foremost a tool for clinicians.It is important to emphasize that DSM-5 does not represent a radical departure from the past, nor does it represent a radical separation from the goals of the RDoC. As we gradually build on our knowledge of mental disorders, we begin bridging the gap between what lies behind us (presumed etiologies based on phenomenology) and what we hope lies ahead (identifiable pathophysiologic etiologies). It is difficult to assess how quickly progress will come about because the thresholds we have set for replication and usability must be as applicable to clinical purposes as they are to research ones. We may be able to examine, for instance, schizophrenia through a genetic framework in terms of researching risk factors and developing treatments, but genetic data are clearly not yet ready for clinical applications (8). Can we ask psychiatrists to use genetic markers to assist in diagnosing a patient with schizophrenia? At this point in time, the answer is no, but the point at which such data can be meaningfully used by clinicians is soon coming, and in the meantime we must be prepared to accept and incorporate genomics and “personalized medicine,” which is now used in diagnoses and therapies for cancer and coagulation disorders.One way in which the authors of DSM-5 are preparing for the future is in proposed changes to the text within each diagnostic chapter. In addition to current subheadings about disorder prevalence, subtypes, specifiers, and differential diagnosis, we propose that DSM-5 also include sections on genetic and physiologic risk factors, gender and cultural aspects of presentation, and clinical expressions across the lifespan. These will not be applicable equally for all disorders. Mood disorders, schizophrenia, Alzheimer's disease, and attention deficit hyperactivity disorder are among the diagnoses that may hold the most immediate promise for the use of this information for clinical purposes. These processes will be facilitated by one of the new, core features of DSM-5—the ability to exist as a “living document” that can be readily updated to reflect changes in our understanding of neuroscience and pathophysiology in a world of (sometimes) rapid and dramatic neuroscience discovery. We have no doubt that future editions will greatly benefit from continuing to incorporate information generated by the RDoC initiative.The evolution of ideas occurs incrementally, with occasional “off the scale” breakthroughs, and when we consider how far psychiatric neuroscience and nosology have come, those hard-fought inches of incremental scientific advances taken cumulatively add up to miles. DSM-5 is a work in progress, and we must await the outcome of several proposed changes before ascertaining their true impact on the field. This includes, for example, the possibility of improving assessments with a uniaxial approach that combines psychiatric and general medical diagnoses but still separately conveys important information about social and environmental contextual factors and disability. While it is clear that the forthcoming version of the manual cannot exhaustively address the limitations and questions posed by the current nosology, progress is our constant goal, and we look forward to working alongside our colleagues in basic and clinical research on this endeavor.Address correspondence to Dr. Kupfer ([email protected]edu).Commentary accepted for publication March 2011.Dr. Regier is Executive Director of the American Psychiatric Institute for Research and Education (APIRE) and Director of the APA Division of Research; he oversees all federal and industry-sponsored research and research training grants in APIRE but receives no external salary funding or honoraria from any government or industry sources. Dr. Kupfer reports no financial relationships with commercial interests.References1. Kupfer DFirst MRegier D (eds): A Research Agenda for DSM-V. Arlington, Va, American Psychiatric Association, 2002Google Scholar2. Andrews GCharney DSSirovatka PJRegier DA (eds): Stress-Induced and Fear Circuitry Disorders: Refining the Research Agenda for DSM-V. Arlington, Va, American Psychiatric Association, 2009Google Scholar3. Andrews G , Goldberg DP , Krueger RF , Carpenter WT , Hyman SE , Sachdev P , Pine DS: Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity? Psychol Med 2009; 39:1993–2000Crossref, Medline, Google Scholar4. Robins E , Guze SB: Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 1970; 126: 983–987Link, Google Scholar5. Regier DA , Narrow WE , Kuhl EA , Kupfer DJ: The conceptual development of DSM-V (commentary). Am J Psychiatry 2009; 166: 645–650Link, Google Scholar6. Insel T , Cuthbert B , Garvey M , Heinssen R , Pine DS , Quinn K , Sanislow C , Wang P: Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010; 167: 748–751Link, Google Scholar7. Hyman SE: The diagnosis of mental disorders: the problem of reification. Annu Rev Clin Psychol 2010; 6: 155–179Crossref, Medline, Google Scholar8. Braff DL , Freedman R: Clinically responsible genetic testing in neuropsychiatric patients: a bridge too far and too soon. Am J Psychiatry 2008; 165: 952–955Link, Google Scholar FiguresReferencesCited byDetailsCited byQualitative analysis of hotspots and intrusive memories after viewing an aversive film highlights their sensory and spatial features29 April 2022 | Scientific Reports, Vol. 12, No. 1Définir ou détecter des pathologies ? Utilisation et interprétation des scores seuils à la lumière du débat dimensions/catégoriesPratiques Psychologiques, Vol. 496The categorical definitions of developmental disorders: Going beyond current models26 May 2022 | Developmental Medicine & Child Neurology, Vol. 64, No. 8Skin conductance response to trauma interview as a candidate biomarker of trauma and related psychopathology in youth resettled as refugees10 June 2022 | European Journal of Psychotraumatology, Vol. 13, No. 1Larval Zebrafish as a Model for Mechanistic Discovery in Mental Health24 June 2022 | Frontiers in Molecular Neuroscience, Vol. 15Is DSM-5 a Failure? Analyzing the Controversies Surrounding the Current American Mental Health Diagnostic ManualPsychiatric Annals, Vol. 52, No. 4Hotspots in the immediate aftermath of trauma – Mental imagery of worst moments highlighting time, space and motionConsciousness and Cognition, Vol. 99Using a Brief Mental Imagery Competing Task to Reduce the Number of Intrusive Memories: Exploratory Case Series With Trauma-Exposed Women20 July 2022 | JMIR Formative Research, Vol. 6, No. 7From measurement to classificatory practice: improving psychiatric classification independently of the opposition between symptom-based and causal approaches2 November 2021 | European Journal for Philosophy of Science, Vol. 11, No. 4A simple cognitive task intervention to prevent intrusive memories after trauma in patients in the Emergency Department: A randomized controlled trial terminated due to COVID-1910 May 2021 | BMC Research Notes, Vol. 14, No. 1Reaching people soon after a traumatic event: an exploratory observational feasibility study of recruitment in the emergency department to deliver a brief behavioral intervention via smartphone to prevent intrusive memories of trauma7 October 2021 | Pilot and Feasibility Studies, Vol. 7, No. 1Philosophy of Psychiatry26 June 2021 | , Vol. 37A New Characterization of Mental Health Disorders Using Digital Behavioral Data: Evidence from Major Depressive Disorder14 July 2021 | Journal of Clinical Medicine, Vol. 10, No. 14Reducing intrusive memories after trauma via a brief cognitive task intervention in the hospital emergency department: an exploratory pilot randomised controlled trial11 January 2021 | Translational Psychiatry, Vol. 11, No. 1Prevention of post-traumatic stress disorder: Lessons learned from a terminated RCT of prolonged exposure24 May 2021 | PLOS ONE, Vol. 16, No. 5Reducing Intrusive Memories of Childhood Trauma Using a Visuospatial Intervention: A Case Study in Iceland (Preprint)23 April 2021 | JMIR Formative ResearchAn alternative approach to future diagnostic standards for major depressive disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 105Research Domains and Brain Network Dysfunction: Towards a New Taxonomy of Neuropsychiatric Illness12 May 2021Models in Depression and Clinical Judgment, or How to Use Different Etiopathogenic Models with a Particular Patient1 January 2022Challenges and Strategies for Current Classifications of Depressive Disorders: Proposal for Future Diagnostic Standards9 April 2021Digitalizing a Brief Intervention to Reduce Intrusive Memories of Psychological Trauma for Health Care Staff Working During COVID-19: Exploratory Pilot Study With Nurses26 May 2021 | JMIR Formative Research, Vol. 5, No. 5Rethinking Categories and Dimensions in the DSM18 November 2020 | The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine, Vol. 45, No. 6Developing thinking around mental health science: the example of intrusive, emotional mental imagery after psychological trauma26 August 2020 | Cognitive Neuropsychiatry, Vol. 25, No. 5The blurred line between anxiety and depression: hesitations on comorbidity, thresholds and hierarchy21 May 2020 | International Review of Psychiatry, Vol. 32, No. 5-6Visuospatial computer game play after memory reminder delivered three days after a traumatic film reduces the number of intrusive memories of the experimental traumaJournal of Behavior Therapy and Experimental Psychiatry, Vol. 67Symptom-based selection of antidepressantsJournal of the Korean Medical Association, Vol. 63, No. 4Considering context: lessons from global mental health22 December 2019 | Australasian Psychiatry, Vol. 28, No. 2Fractures in the framework: limitations of classification systems in psychiatry 1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 22, No. 1Controversies in the Classification and Diagnosis of Personality DisordersClassification Systems of Mental Disorders: Where Did We Go Wrong?9 June 2020Familiar Factors in the Activation of Schizophrenic Symptoms: A Study in a Students' Engineering SamplePublic, health professional and legislator perspectives on the concept of psychiatric disease: a population-based survey4 June 2019 | BMJ Open, Vol. 9, No. 6, Vol. 1192Journal of Medical Humanities, Vol. 40, No. 3The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine, Vol. 44, No. 1Psychiatry Investigation, Vol. 16, No. 2Psychiatry Investigation, Vol. 16, No. 9Multiple memory systems, multiple time points: how science can inform treatment to control the expression of unwanted emotional memories29 January 2018 | Philosophical Transactions of the Royal Society B: Biological Sciences, Vol. 373, No. 1742Molecular Psychiatry, Vol. 23, No. 3The True North Strong and Free? Opportunities for Improving Canadian Mental Health Care and Education by Adopting the WHO’s ICD-11 Classification30 June 2017 | The Canadian Journal of Psychiatry, Vol. 62, No. 10A Handbook for the Study of Mental Health28 May 2018 | , Vol. 56Aporia of power: On the crises, science, and internal dynamics of the mental health field15 June 2016 | European Journal for Philosophy of Science, Vol. 7, No. 2The DSM5/RDoC debate on the future of mental health research: implication for studies on human stress and presentation of the signature bank16 February 2017 | Stress, Vol. 20, No. 1Depression and Anxiety, Vol. 34, No. 7Symptom and Context: The Issue of Validity in Diagnosis25 February 2017Mind & Society, Vol. 16, No. 1-2Psychiatric Taxonomies and Corresponding MeasuresDiagnosisBrain Connectivity, Vol. 7, No. 5Hope and doubt in the promise of neuroimaging: The case of autism spectrum disorder29 July 2016 | Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, Vol. 20, No. 5Neurogenetics Approaches to Mapping Pathways in Developmental Psychopathology10 February 2016Current Psychiatry Reports, Vol. 18, No. 3L'Encéphale, Vol. 42, No. 6The Lancet Psychiatry, Vol. 3, No. 5Biological Psychiatry, Vol. 79, No. 1Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 55, No. 7Psychoneuroendocrinology, Vol. 66Social Science & Medicine, Vol. 166CNS Spectrums, Vol. 21, No. 4BioSocieties, Vol. 11, No. 2The National Institute of Mental Health Research Domain CriteriaJournal of Nervous & Mental Disease, Vol. 204, No. 1Behavioral Sciences, Vol. 6, No. 1Understanding the Neural Circuitry of Emotion Regulation, Vol. 10European Archives of Psychiatry and Clinical Neuroscience, Vol. 265, No. 1European Archives of Psychiatry and Clinical Neuroscience, Vol. 265, No. 2Current Psychiatry Reports, Vol. 17, No. 11NeuropsychiatryMetabolism, Vol. 64, No. 3Neuroscience & Biobehavioral Reviews, Vol. 48Social Theory & Health, Vol. 13, No. 2Psychological Inquiry, Vol. 26, No. 3Psychological Inquiry, Vol. 26, No. 3Frontiers in Psychiatry, Vol. 6Challenges of creating synergy between global mental health and cultural psychiatry31 October 2014 | Transcultural Psychiatry, Vol. 51, No. 6DSM-5 : tempête dans un verre d’eau ou tsunami ? Origines et conséquences d’une mise à jour controverséeNeuropsychiatrie de l'Enfance et de l'Adolescence, Vol. 62, No. 6After DSM-5Harvard Review of Psychiatry, Vol. 22, No. 4Nosological Reflections22 January 2014 | Society and Mental Health, Vol. 4, No. 2Nosology and Classification4 April 2014The Cycle of Classification: DSM-I Through DSM-5Annual Review of Clinical Psychology, Vol. 10, No. 1Journal of Autism and Developmental Disorders, Vol. 44, No. 7CNS Drugs, Vol. 28, No. 4Academic Psychiatry, Vol. 38, No. 1The Lancet Psychiatry, Vol. 1, No. 4Asian Journal of Psychiatry, Vol. 7International Journal of Clinical and Health Psychology, Vol. 14, No. 3Schizophrenia Research, Vol. 152, No. 2-3Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, Vol. 46Bipolar Disorders, Vol. 16, No. 2Clinical Psychology: Science and Practice, Vol. 21, No. 3A 60-Year Climb on the Mountain of NosologyJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 52, No. 12Classification systems in psychiatryCurrent Opinion in Psychiatry, Vol. 26, No. 5Diagnostic Classification Past, Present, and Future: Implications for PharmacotherapyJournal of Psychosocial Nursing and Mental Health Services, Vol. 51, No. 4A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology22 May 2012 | Molecular Psychiatry, Vol. 18, No. 3Psychiatry's Integration with Medicine: The Role of DSM-5Annual Review of Medicine, Vol. 64, No. 1Psychotherapeut, Vol. 58, No. 3Journal of Autism and Developmental Disorders, Vol. 43, No. 12Increasing Prevalence and the Problem of DiagnosisAutism Symptoms Exist but the Disorder Remains ElusiveAsian Journal of Psychiatry, Vol. 6, No. 2Asian Journal of Psychiatry, Vol. 6, No. 3Clinical Psychology Review, Vol. 33, No. 7Schizophrenia Research, Vol. 150, No. 1Schizophrenia Research, Vol. 150, No. 1International Journal of Neuropsychopharmacology, Vol. 16, No. 7Nature, Vol. 496, No. 7446Nature Reviews Drug Discovery, Vol. 12, No. 9Nature Reviews Neuroscience, Vol. 14, No. 11Schizophrenia Bulletin, Vol. 39, No. 4Psychopharm Review, Vol. 48, No. 5Disease Markers, Vol. 35BMC Medicine, Vol. 11, No. 1BMC Medicine, Vol. 11, No. 1Clinical Schizophrenia & Related Psychoses, Vol. 7, No. 1Psychiatric Clinics of North America, Vol. 35, No. 3Psychology and Psychotherapy: Theory, Research and Practice, Vol. 85, No. 2Neuroimaging in Eating Disorders: Coming of AgeKamryn T. Eddy, Ph.D., and Scott L. Rauch, M.D.1 November 2011 | American Journal of Psychiatry, Vol. 168, No. 11DSM-10: Coming Soon to a Psychiatric Practice Near YouJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 50, No. 10Progress in Neurobiology, Vol. 95, No. 4 Volume 168Issue 7 July 2011Pages 672-674 Metrics PDF download History Accepted 1 March 2011 Published online 1 July 2011 Published in print 1 July 2011